J.W. (Hans) HOFSTRAAT
Vice President Philips Research,
Healthcare Strategic Partnerships
Hans Hofstraat is Vice President in Philips Research, globally responsible for partnerships and Open Innovation for Philips' healthcare research program.
Hans Hofstraat completed his thesis (Free University, Amsterdam) and post-doctoral work (ETH, Zürich, Switzerland) on low-temperature high-resolution luminescence spectroscopy.
After career steps in marine environmental research (with the Dutch Public Works Department in The Hague and Rijswijk) and in the chemical industry (with Akzo Nobel Central Research, Arnhem, The Netherlands), he joined Philips Research in Eindhoven (The Netherlands) in 1998. From 1998-2008 he also was part-time professor in the Institute of Molecular Chemistry at the University of Amsterdam. Since January 15, 2007 he is responsible for Healthcare Strategic Partnerships in Philips Research worldwide, actively driving the Open Innovation approach to Philips' Healthcare research program. Next to his work at Philips he holds several positions in (inter)national advisory bodies. Amongst others he is Member of the Advisory Group of the European FP7 research program on Nanosciences, Nanotechnologies, Materials and New Production Technologies (NMP), Member of the Advisory Board of EATRIS, the European Advanced Translational Infrastructure for Medicine (part of the European Science Foundation's Research Infrastructure initiative), and Member of the External Advisory Board of the ERA-Net EuroNanoMed. He is founder and chairman of the Advisory Board of the Dutch public-private partnership CTMM, the Center for Translational Molecular Medicine, and member of the Dutch Council for Health Research. Hofstraat authored about 190 publications with an h-index of 32. He holds 9 granted US patents, and a total of over 80 patent (application)s in various countries from 25 patent families in various fields.
Innovating Healthcare Together: The Open Innovation Way
( 1.05 MB)
The introduction of meaningful innovations in healthcare requires joint efforts of multiple stakeholders. Successful translation of innovations into the practice of healthcare is ensured by drawing inspiration from unmet needs, taking advantage of advances in biomedical sciences and in medical technologies, and by engaging with clinical leaders and professionals. Particularly, opportunities presented by convergent technologies require collaborations between companies transgressing the boundaries between life sciences and advanced technologies. Open Innovation partnerships involving public and private parties lead the way from research to market. Examples from Philips' research program will be used as illustration.